• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发从肺癌患者 FACT-L 估算 EQ-5D-5L 的算法:一项映射研究。

Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.

机构信息

Department of Thoracic Surgery Sichuan Clinical Research Center for Cancer Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.

Nursing Department, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu, China.

出版信息

Qual Life Res. 2024 Mar;33(3):805-816. doi: 10.1007/s11136-023-03567-y. Epub 2023 Dec 26.

DOI:10.1007/s11136-023-03567-y
PMID:38148367
Abstract

OBJECTIVE

This study aimed to develop a mapping algorithm to evaluate the EQ-5D-5L according to the FACT-L when the EQ-5D-5L is not available.

METHODS

EQ-5D-5L and FACT-L data were collected from patients with lung cancer in Departments of Thoracic Surgery, Medical Oncology, Radiation Oncology, Sichuan Cancer Hospital. We used the ordinary least squares model (OLS), Tobit model (Tobit), two-part model (TPM), beta mixture regression (BM), and censored least absolute deviation model (CLAD) to map the results of the FACT-L according to EQ-5D-5L scores. To establish these models, the total score, dimension scores, squared items, and interaction items were introduced. Performance metrics including Adjusted R, root mean square error (RMSE), and mean absolute error (MAE) were used to select the optimized model.

RESULTS

The model with the best mapping performance was the BM model (BETAMIX4) with the PWB (physical well-being) dimension, FWB (functional well-being) dimension, the squared term of the PWB dimension, and the squared term of the FWB dimension as covariates. The final prediction metrics were Adjusted R = 0.695, RMSE = 0.206, and MAE = 0.109. Fivefold cross-validation (CV) results also demonstrated that the BM model had the best mapping power.

CONCLUSIONS

This study developed an optimized mapping algorithm to predict the utility index from the FACT-L to the EQ-5D-5L, which provides an effective alternative reference for EQ-5D-5L estimation when the preference-based health utility values were unavailable.

摘要

目的

本研究旨在开发一种映射算法,以根据 FACT-L 评估 EQ-5D-5L,当 EQ-5D-5L 不可用时。

方法

在四川省肿瘤医院胸外科、肿瘤内科、放疗科收集肺癌患者的 EQ-5D-5L 和 FACT-L 数据。我们使用普通最小二乘法(OLS)、Tobit 模型(Tobit)、两部分模型(TPM)、β混合回归(BM)和截尾最小绝对偏差模型(CLAD)根据 EQ-5D-5L 评分映射 FACT-L 的结果。为了建立这些模型,引入了总评分、维度评分、平方项和交互项。使用调整后的 R、均方根误差(RMSE)和平均绝对误差(MAE)等性能指标来选择优化模型。

结果

具有最佳映射性能的模型是 BM 模型(BETAMIX4),其协变量为 PWB(身体幸福感)维度、FWB(功能幸福感)维度、PWB 维度的平方项和 FWB 维度的平方项。最终预测指标为调整后的 R=0.695、RMSE=0.206 和 MAE=0.109。五折交叉验证(CV)结果也表明,BM 模型具有最佳的映射能力。

结论

本研究开发了一种优化的映射算法,以从 FACT-L 预测 EQ-5D-5L 的效用指数,当偏好健康效用值不可用时,为 EQ-5D-5L 估计提供了有效的替代参考。

相似文献

1
Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study.开发从肺癌患者 FACT-L 估算 EQ-5D-5L 的算法:一项映射研究。
Qual Life Res. 2024 Mar;33(3):805-816. doi: 10.1007/s11136-023-03567-y. Epub 2023 Dec 26.
2
Mapping study of papillary thyroid carcinoma in China: Predicting EQ-5D-5L utility values from FACT-H&N.中国甲状腺乳头癌的映射研究:从 FACT-H&N 预测 EQ-5D-5L 效用值。
Front Public Health. 2023 Feb 23;11:1076879. doi: 10.3389/fpubh.2023.1076879. eCollection 2023.
3
Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.使用多种建模方法将 FACT-B 映射到 EQ-5D-5L:来自中国乳腺癌患者的数据。
Health Qual Life Outcomes. 2019 Oct 15;17(1):153. doi: 10.1186/s12955-019-1224-8.
4
Mapping the SRS-22r questionnaire onto the EQ-5D-5L utility score in patients with adolescent idiopathic scoliosis.将SRS-22r问卷映射到青少年特发性脊柱侧凸患者的EQ-5D-5L效用评分上。
PLoS One. 2017 Apr 17;12(4):e0175847. doi: 10.1371/journal.pone.0175847. eCollection 2017.
5
Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia.将 FACT-G、FAACT 和 FACIT-F 的健康相关生活质量评分映射到非小细胞肺癌恶病质的基于偏好的 EQ-5D-5L 效用值上。
Eur J Health Econ. 2019 Mar;20(2):181-193. doi: 10.1007/s10198-017-0930-6. Epub 2017 Sep 25.
6
Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study.利用全国健康和福利研究中特应性皮炎患者的数据,将皮肤病生活质量指数(DLQI)评分映射到 EQ-5D 效用评分。
Qual Life Res. 2020 Sep;29(9):2529-2539. doi: 10.1007/s11136-020-02499-1. Epub 2020 Apr 15.
7
Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease.将 ALSFRS-R 和 ALSUI 与运动神经元病患者的 EQ-5D 进行映射。
Value Health. 2018 Nov;21(11):1322-1329. doi: 10.1016/j.jval.2018.05.005. Epub 2018 Jul 26.
8
Direct and Indirect Mapping of Assessment of Quality of Life - 6 Dimensions (AQoL-6D) Onto EQ-5D-5L Utilities Using Data From a Multicenter, Cross-Sectional Study of Malaysians With Chronic Heart Failure.直接和间接映射评估生命质量 - 6 维度(AQoL-6D)到 EQ-5D-5L 效用,使用来自马来西亚慢性心力衰竭患者的多中心、横断面研究的数据。
Value Health. 2024 Dec;27(12):1762-1770. doi: 10.1016/j.jval.2024.07.016. Epub 2024 Aug 9.
9
Developing mapping algorithms to predict EQ-5D health utility values from Bath Ankylosing Spondylitis Disease Activity Index and Bath Ankylosing Spondylitis Functional Index among patients with Ankylosing Spondylitis.开发映射算法,以根据强直性脊柱炎患者的巴斯强直性脊柱炎疾病活动指数和巴斯强直性脊柱炎功能指数预测EQ-5D健康效用值。
Health Qual Life Outcomes. 2024 Aug 7;22(1):61. doi: 10.1186/s12955-024-02276-5.
10
Mapping EORTC-QLQ-C30 onto EQ-5D-5L Index in Indonesian Cancer Patients.将 EORTC-QLQ-C30 映射到印度尼西亚癌症患者的 EQ-5D-5L 指数上。
Asian Pac J Cancer Prev. 2023 Apr 1;24(4):1125-1130. doi: 10.31557/APJCP.2023.24.4.1125.

引用本文的文献

1
Deriving Health Utility Values Using Mapping Methods Among the Chinese Population: A Systematic Review.运用映射方法推导中国人群的健康效用值:一项系统评价
Appl Health Econ Health Policy. 2025 Aug 18. doi: 10.1007/s40258-025-00992-7.
2
Big data-driven machine learning: transforming multi-omics lung cancer research.大数据驱动的机器学习:变革多组学肺癌研究
Discov Oncol. 2025 May 24;16(1):913. doi: 10.1007/s12672-025-02645-6.

本文引用的文献

1
Incidence and risk factors of symptomatic thrombosis related to peripherally inserted central catheter in patients with lung cancer.肺癌患者外周置入中心静脉导管相关症状性血栓的发生率及危险因素。
J Adv Nurs. 2021 Mar;77(3):1284-1292. doi: 10.1111/jan.14666. Epub 2020 Nov 29.
2
What Is a Valid Mapping Algorithm in Cost-Utility Analyses? A Response From a Missing Data Perspective.成本效用分析中的有效映射算法是什么?从缺失数据角度的回应。
Value Health. 2020 Sep;23(9):1218-1224. doi: 10.1016/j.jval.2020.03.020. Epub 2020 Aug 1.
3
Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing.
比较 EQ-5D-3L 和 EQ-5D-5L 在常见癌症中的表现:工具选择建议。
Qual Life Res. 2021 Mar;30(3):841-854. doi: 10.1007/s11136-020-02636-w. Epub 2020 Sep 15.
4
Mapping WOMAC Onto the EQ-5D-5L Utility Index in Patients With Hip or Knee Osteoarthritis.将 WOMAC 映射到髋或膝关节骨关节炎患者的 EQ-5D-5L 效用指数上。
Value Health. 2020 Mar;23(3):379-387. doi: 10.1016/j.jval.2019.09.2755. Epub 2019 Nov 8.
5
'Mapping' Health State Utility Values from Non-preference-Based Measures: A Systematic Literature Review in Rare Diseases.从非偏好性测量指标映射健康状态效用值:罕见病的系统文献回顾。
Pharmacoeconomics. 2020 Jun;38(6):557-574. doi: 10.1007/s40273-020-00897-4.
6
Mapping function from FACT-B to EQ-5D-5 L using multiple modelling approaches: data from breast cancer patients in China.使用多种建模方法将 FACT-B 映射到 EQ-5D-5L:来自中国乳腺癌患者的数据。
Health Qual Life Outcomes. 2019 Oct 15;17(1):153. doi: 10.1186/s12955-019-1224-8.
7
An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility Values.健康相关生活质量测量指标与通用偏好量表关联(或映射)以生成效用值的研究的更新系统评价。
Appl Health Econ Health Policy. 2019 Jun;17(3):295-313. doi: 10.1007/s40258-019-00467-6.
8
Overview, Update, and Lessons Learned From the International EQ-5D-5L Valuation Work: Version 2 of the EQ-5D-5L Valuation Protocol.概述、更新以及从国际 EQ-5D-5L 估值工作中吸取的经验教训:EQ-5D-5L 估值议定书第 2 版。
Value Health. 2019 Jan;22(1):23-30. doi: 10.1016/j.jval.2018.05.010. Epub 2019 Jan 2.
9
Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients.将癌症患者专用的 QLQ-C30 量表映射到通用的 EQ-5D-5L 和 SF-6D 量表上。
Expert Rev Pharmacoecon Outcomes Res. 2019 Feb;19(1):89-96. doi: 10.1080/14737167.2018.1517046. Epub 2018 Sep 3.
10
Development of Methods for the Mapping of Utilities Using Mixture Models: Mapping the AQLQ-S to the EQ-5D-5L and the HUI3 in Patients with Asthma.利用混合模型进行实用工具映射方法的开发:将 AQLQ-S 映射到哮喘患者的 EQ-5D-5L 和 HUI3。
Value Health. 2018 Jun;21(6):748-757. doi: 10.1016/j.jval.2017.09.017. Epub 2017 Dec 14.